hepatitis B vaccine

Drug identity checked against registry records

Also recorded as Engerix-B

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)NCT01311674Emergent BioSolutionsPhase 3Terminated2011-03-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.